Molecular imaging techniques, such as 68Ga-PSMA PET/CT, combined with 177Lu therapy, allow for enhanced tumor localization and precision targeting, thus offering a powerful tool for early intervention (126, 246). The gene discussed is FOLH1; the disease is neoplasm.